October 14, 2016
2 min watch
Save

VIDEO: Cross-linking underway in US since FDA approval

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — At the Ophthalmology Innovation Summit here, Avedro's chief medical officer Rajesh K. Rajpal, MD, talks about the company's progress with cornea collagen cross-linking in the U.S. since FDA approval in April 2016, as well as the trials of photorefractive intrastromal cross-linking that are underway outside the U.S.